Why Does Wegovy Sting After Injection, and What Can You Do About It?

Stinging is a recognised and common reaction to subcutaneous semaglutide injections, typically settling within a minute or two of the injection.
The main drivers are solution acidity (pH), preservatives, and the mechanics of fluid entering subcutaneous tissue — not a fault with the pen or the medicine.
Cold solution, rubbing the site, and injecting too quickly all reliably make the sting worse and are easy to change.
Persistent redness, swelling, or stinging that gets worse over several weeks rather than better warrants a conversation with your prescriber or the MHRA Yellow Card scheme.

A stinging sensation after a Wegovy injection is common and, in most cases, entirely normal. The feeling typically peaks in the first minute or two, then fades. It is caused by the pH of the semaglutide solution, the preservatives in the formula, and the small volume of fluid entering the subcutaneous tissue at once. It does not mean anything has gone wrong, and it is not a sign that the medicine is unsafe. That said, technique matters enormously: where you inject, how cold the pen is, and what you do with the site in the moments after all affect how much you feel. This page walks through the practical steps, in order, that most people find genuinely helpful. Wegovy is a prescription-only medicine and any concerns specific to your health, or stinging that is worsening rather than settling, should go to your prescriber or pharmacist.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Step-by-step: the things that actually reduce stinging for most people

Step 1 — Let the pen warm up before you use it

This is the step that makes the biggest difference for most people, and it costs nothing. Wegovy pens are stored in the fridge at 2–8°C, and injecting cold solution into skin is much more likely to sting than injecting it at room temperature. Take the pen out at least 30 minutes before you plan to use it and leave it sitting on a clean surface at room temperature. Some people do this when they put the kettle on in the morning, since the pen needs the same rough window of time. Do not try to warm it faster under hot water or in a microwave; that risks damaging the medicine. Simply leaving it out is enough. The step-by-step guide to Wegovy injections covers this and the other preparation steps in full, including how to check the pen before use.

The NHS patient information for semaglutide confirms that the pen may be kept at room temperature for a limited period, for the exact window, check the Patient Information Leaflet that comes in your box, since that figure is the authoritative one for your specific pen.

Step 2, Choose the right site and prepare it carefully

The three licensed injection sites are the abdomen (at least 5 cm from the navel), the front of the thigh, and the upper arm. Rotating between sites and between spots within each site matters for two reasons: it gives tissue time to recover, and repeatedly injecting into one small area increases the chance of a localised reaction. If a site feels tender or looks slightly raised from a previous injection, skip it entirely for that week.

Before injecting, clean the chosen spot with an alcohol swab and allow it to dry completely, 10 to 20 seconds is enough. Injecting through still-wet alcohol is a common cause of extra stinging. Alcohol swabs are a small thing to have to hand every week. Once the skin is dry, pinch the area gently if you are lean or injecting into the arm, insert the needle at a 90-degree angle, and hold the pen in place for the full count stated in the instructions. If you notice a firm bump or lump forming at a previous injection spot, our guide to what causes a lump after injecting Wegovy explains what that usually means and when to flag it to your prescriber.

After the pen clicks and the dose is complete, lift it straight out without rubbing the site. Rubbing does not help absorption and often makes localised soreness worse.

Step 3, Understand what is normal and what to watch for

A sting, a brief ache, or a small amount of redness at the site in the hours after injecting is within the range of normal. The NHS semaglutide medicines page lists injection-site reactions (including redness, swelling, and bruising) as common side effects. Most settle without intervention. For related patterns seen with semaglutide in its other pen formats, the same kind of site reactions appear consistently across subcutaneous GLP-1 injections, as detailed on the semaglutide injection-site stinging page.

What is worth escalating: stinging that gets noticeably worse from week to week rather than better; a site reaction that spreads beyond a few centimetres; signs of infection (increasing warmth, spreading redness, pus, fever); or a hardened lump that does not fade after a couple of weeks. These are not typical injection-site reactions, and your prescriber needs to know. You can also report suspected side effects directly to the MHRA through the Yellow Card reporting service, it exists precisely for experiences like this and helps regulators track real-world safety signals.

Step 4, Small needle, correct depth, consistent habit

Pen needles vary in length, and a needle that is too long for your build risks going intramuscular rather than subcutaneous. Intramuscular injections hurt more and can cause harder, longer-lasting site reactions. If you are using standard pen needles compatible with your Wegovy device, shorter options (4–6 mm) are generally adequate for subcutaneous delivery in most adults. Checking that the needle is securely attached and using a fresh needle each time matters too: a needle used more than once becomes slightly blunted, which increases trauma to the tissue and therefore stinging.

Building a consistent weekly routine helps. Some people find a fixed injection day and time removes the chance of an accidental double-dose or a missed week through forgetfulness. If you ever need to think through shifting your Wegovy injection day, there is specific guidance on doing that safely. Consistency in technique accumulates: most people who struggle with stinging in weeks one and two find it noticeably less intense once the routine settles and they have identified their best site and warm-up habits.

If you are weighing up the broader experience of injectable semaglutide versus other options, the overview of weight loss injections including Ozempic sets out what is currently available in the UK through a private regulated route.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions